Sigma Planning Corp Has $331,000 Stock Holdings in SPDR S&P Biotech ETF $XBI

Sigma Planning Corp reduced its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 86.3% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 2,090 shares of the exchange traded fund’s stock after selling 13,113 shares during the period. Sigma Planning Corp’s holdings in SPDR S&P Biotech ETF were worth $331,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in XBI. Compound Planning Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 0.7% during the first quarter. Compound Planning Inc. now owns 10,889 shares of the exchange traded fund’s stock valued at $1,391,000 after acquiring an additional 75 shares during the period. Dynamic Wealth Strategies LLC increased its position in SPDR S&P Biotech ETF by 3.8% in the fourth quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock worth $268,000 after purchasing an additional 80 shares during the period. PeakShares LLC raised its holdings in SPDR S&P Biotech ETF by 5.2% during the 1st quarter. PeakShares LLC now owns 1,684 shares of the exchange traded fund’s stock worth $215,000 after purchasing an additional 84 shares during the last quarter. Commerce Bank raised its holdings in SPDR S&P Biotech ETF by 2.8% during the 4th quarter. Commerce Bank now owns 3,260 shares of the exchange traded fund’s stock worth $397,000 after purchasing an additional 90 shares during the last quarter. Finally, Moors & Cabot Inc. lifted its position in SPDR S&P Biotech ETF by 3.8% during the 3rd quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock valued at $272,000 after purchasing an additional 100 shares during the period.

SPDR S&P Biotech ETF Trading Up 1.2%

Shares of NYSEARCA XBI opened at $165.37 on Thursday. SPDR S&P Biotech ETF has a 1 year low of $92.49 and a 1 year high of $169.89. The firm’s 50-day moving average is $157.76 and its 200-day moving average is $140.05. The firm has a market capitalization of $10.80 billion, a PE ratio of 11.47 and a beta of 0.83.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.